Artikler med mandater om offentlig tilgang - Boidot RomainLes mer
Ikke tilgjengelige noe sted: 3
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
M Bruchard, M Geindreau, A Perrichet, C Truntzer, E Ballot, R Boidot, ...
Nature Immunology 23 (2), 262-274, 2022
Mandater: Agence Nationale de la Recherche, Swiss Cancer League
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin
J Galaine, C Turco, C Vauchy, B Royer, P Mercier‐Letondal, L Queiroz, ...
International journal of cancer 145 (11), 3112-3125, 2019
Mandater: Swiss Cancer League
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects
R Mary, F Chalmin, T Accogli, M Bruchard, C Hibos, J Melin, C Truntzer, ...
Cancer Immunology Research 10 (7), 900-916, 2022
Mandater: Agence Nationale de la Recherche, Swiss Cancer League
Tilgjengelige et eller annet sted: 48
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
L Derosa, B Routy, AM Thomas, V Iebba, G Zalcman, S Friard, J Mazieres, ...
Nature medicine 28 (2), 315-324, 2022
Mandater: US National Institutes of Health, Canadian Institutes of Health Research …
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation
M Bruchard, C Rebé, V Derangère, D Togbé, B Ryffel, R Boidot, ...
Nature immunology 16 (8), 859-870, 2015
Mandater: National Institute of Health and Medical Research, France
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
A Fluckiger, R Daillère, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ...
Science 369 (6506), 936-942, 2020
Mandater: National Institute of Health and Medical Research, France, European …
Accumulation of MDSC and Th17 cells in patients with metastatic colorectal cancer predicts the efficacy of a FOLFOX–bevacizumab drug treatment regimen
E Limagne, R Euvrard, M Thibaudin, C Rébé, V Derangère, A Chevriaux, ...
Cancer research 76 (18), 5241-5252, 2016
Mandater: National Institute of Health and Medical Research, France, European Commission
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
F Végran, H Berger, R Boidot, G Mignot, M Bruchard, M Dosset, ...
Nature immunology 15 (8), 758-766, 2014
Mandater: National Institute of Health and Medical Research, France
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells
SY Yang, P Lejault, S Chevrier, R Boidot, AG Robertson, JMY Wong, ...
Nature communications 9 (1), 4730, 2018
Mandater: European Commission
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
M Dosset, TR Vargas, A Lagrange, R Boidot, F Végran, A Roussey, ...
Oncoimmunology 7 (6), e1433981, 2018
Mandater: National Institute of Health and Medical Research, France, European Commission
A natural polyphenol exerts antitumor activity and circumvents anti–PD-1 resistance through effects on the gut microbiota
M Messaoudene, R Pidgeon, C Richard, M Ponce, K Diop, M Benlaifaoui, ...
Cancer Discovery 12 (4), 1070-1087, 2022
Mandater: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Sirtuin-1 activation controls tumor growth by impeding Th17 differentiation via STAT3 deacetylation
E Limagne, M Thibaudin, R Euvrard, H Berger, P Chalons, F Vegan, ...
Cell reports 19 (4), 746-759, 2017
Mandater: National Institute of Health and Medical Research, France, European Commission
Antibiotic use does not appear to influence response to nivolumab
C Kaderbhai, C Richard, JD Fumet, A Aarnink, P Foucher, B Coudert, ...
Anticancer research 37 (6), 3195-3200, 2017
Mandater: Swiss Cancer League
Transcriptional regulation of the survivin gene
R Boidot, F Végran, S Lizard-Nacol
Molecular biology reports 41, 233-240, 2014
Mandater: Swiss Cancer League
Cleaved caspase-3 transcriptionally regulates angiogenesis-promoting chemotherapy resistance
A Bernard, S Chevrier, F Beltjens, M Dosset, E Viltard, A Lagrange, ...
Cancer research 79 (23), 5958-5970, 2019
Mandater: Agence Nationale de la Recherche, Swiss Cancer League
IRF8-dependent molecular complexes control the Th9 transcriptional program
E Humblin, M Thibaudin, F Chalmin, V Derangère, E Limagne, C Richard, ...
Nature communications 8 (1), 2085, 2017
Mandater: US National Institutes of Health, European Commission
Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions
M Thibaudin, M Chaix, R Boidot, F Végran, V Derangère, E Limagne, ...
Oncoimmunology 5 (1), e1055444, 2016
Mandater: European Commission
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells
I Benoit-Lizon, E Jacquin, TR Vargas, C Richard, A Roussey, L Dal Zuffo, ...
Journal for immunotherapy of cancer 10 (1), e003459, 2022
Mandater: US Department of Defense, US National Institutes of Health, National …
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
M Thibaudin, JD Fumet, B Chibaudel, J Bennouna, C Borg, ...
Nature Medicine 29 (8), 2087-2098, 2023
Mandater: National Institute of Health and Medical Research, France, Swiss Cancer League
Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma
F Végran, R Boidot, F Bonnetain, M Cadouot, S Chevrier, S Lizard-Nacol
Endocrine-related cancer 18 (6), 783-792, 2011
Mandater: US National Institutes of Health
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram